Ten firms covering Xometry have produced ratings that average out to a Hold recommendation. Of those, one analyst recommends Sell, four recommend Hold and five recommend Buy. The mean 12-month price objective across these analysts stands at $57.89. Notably, Citizens JMP and JMP Securities both elevated their targets to $75, Wedbush raised its target to $70 and JPMorgan Chase upgraded Xometry to Overweight with a $70 objective. Cantor Fitzgerald boosted its projection to $60 while maintaining a Neutral view.

Chief Financial Officer James Miln disposed of 599 shares at an average of $62.11 on November 7, reducing his holding by 0.42% to 141,796 shares. Subir Dutt sold 2,075 shares at $60.00 on November 19, trimming his stake by 2.83% to 71,348 shares. Overall, insiders have sold 12,005 shares worth $631,147 over the past 90 days, representing 9.66% of the company’s share count.

Hood River Capital Management increased its stake by 29.7% in Q2, adding 92,741 shares to reach 404,853 shares valued at $13.68 million. Squarepoint Ops lifted its position by 33.9% to 183,799 shares worth $6.21 million. New entrants include LVW Advisors with a $388,000 stake, Sheets Smith Investment Management with $347,000 and Zweig DiMenna Associates with $1.61 million invested. Institutional investors now account for 97.31% of total shares outstanding.

In the third quarter, Xometry delivered revenue of $180.72 million, a 27.5% increase year-over-year, matching analysts’ estimate of $0.11 EPS. The firm’s return on equity remained negative at 6.59% and net margin was –9.80%. The company’s proprietary Instant Quoting Engine continues to drive growth across CNC machining, 3D printing and other custom manufacturing services, with overseas markets contributing to a diversified revenue base.